Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose V Venero

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The American Journal of Cardiology|October 23, 2008
Effectiveness of thrice weekly ezetimibeCarmelo V Venero, Jose V Venero, Richard L Seip, et al.
The American Journal of Cardiology|February 27, 2010
Lipid-lowering efficacy of red yeast rice in a population intolerant to statinsCarmelo V Venero, Jose V Venero, Dale C Wortham, et al.
ESC Heart Failure|October 7, 2016
Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centreJose V Venero, Mark Doyle, Moneal Shah, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|October 23, 2008
Effectiveness of thrice weekly ezetimibeCarmelo V Venero, Jose V Venero, Richard L Seip, et al.
The American Journal of Cardiology|February 27, 2010
Lipid-lowering efficacy of red yeast rice in a population intolerant to statinsCarmelo V Venero, Jose V Venero, Dale C Wortham, et al.
ESC Heart Failure|October 7, 2016
Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centreJose V Venero, Mark Doyle, Moneal Shah, et al.
Pageof 1